Retinas: New potential clues in diagnosing, treating Alzheimer's

November 17, 2020

LOS ANGELES (Nov. 17, 2020) -- A study led by the Cedars-Sinai Department of Neurosurgery has identified certain regions in the retina - the lining found in the back of the eye - that are more affected by Alzheimer's disease than other areas. The findings may help physicians predict changes in the brain as well as cognitive deterioration, even for patients experiencing the earliest signs of mild impairment.

"These clues can occur very early on in the progression of Alzheimer's disease - several decades before symptoms appear," said Maya Koronyo-Hamaoui, PhD, associate professor of Neurosurgery and Biomedical Sciences and co-corresponding author of the study. "Detecting these signs can help diagnose the disease more accurately, allowing for earlier and more effective treatment intervention."

Alzheimer's disease is the most common form of dementia, a group of brain disorders characterized by a general loss of mental abilities, including memory, judgment, language and abstract thinking.

The findings of the new study, published in the journal Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, were from a clinical trial involving people older than 40 who were showing signs of cognitive decline.

In the trial, investigators used a noninvasive technique known as sectoral retinal amyloid imaging to capture retinal images in participants. The retina, which is directly connected to the brain, is the only central nervous system tissue accessible for patient-friendly, high-resolution and noninvasive imaging.

The images were then analyzed using a new process that could identify certain peripheral regions in the retina that corresponded better to brain damage and cognitive status. In studying the images, scientists could detect patients with an increased buildup of retinal amyloid protein, signifying a higher likelihood of developing Alzheimer's disease or cognitive impairments.

These findings build upon pioneering research in 2010 in which Koronyo-Hamaoui and her team identified a pathological hallmark of Alzheimer's disease, amyloid beta-protein deposits, in retinal tissues from deceased patients. The team then developed a methodology to detect retinal amyloid beta-protein plaques in living patients suffering from the disease.

In another research study, this one involving laboratory mice, that was recently published in the journal Aging Cell, Koronyo-Hamaoui, premed student Jonah Doustar and others on the research team, further validated the role of the retina in displaying hallmark signs of Alzheimer's disease and identified a potential treatment to combat the disease.

"We found that increased levels of retinal amyloid-beta peptides correlated with levels found in brain tissues, even in the latest stages of Alzheimer's disease," said Koronyo-Hamaoui. "We also suggested a particular type of immune-modulation therapy that may combat the disease by reducing toxic proteins and harmful inflammation in the brain and, in return, enhancing a protective type of immune response that preserved the connections between neurons, which are tightly connected to cognition."

Both studies show promise for diagnosing and treating Alzheimer's disease, a condition affecting more than 5.5 million people in the U.S., said Keith Black, MD, professor and chair of the Department of Neurosurgery

"This work may guide future brain and retinal imaging studies to detect Alzheimer's disease, assess disease progression and identify first-ever treatment options," Black said.
Disclosures: Yosef Koronyo, Maya Koronyo-Hamaoui, and Keith L. Black are co-founders and stockholders of NeuroVision Imaging Inc., 1395 Garden Highway, Suite 250, Sacramento, CA 95833, USA, and they are the co-inventors of U.S. patents related to retinal imaging and Alzheimer's disease. Sally Frautschy is co-inventor on U.S. patent US9192644B2 for a curcumin formulation and is a co-founding member of Optimized Curcumin Longvida.

Read more from the Cedars-Sinai Blog: Better Brain Surgery

Cedars-Sinai Medical Center

Related Brain Articles from Brightsurf:

Glioblastoma nanomedicine crosses into brain in mice, eradicates recurring brain cancer
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

Children with asymptomatic brain bleeds as newborns show normal brain development at age 2
A study by UNC researchers finds that neurodevelopmental scores and gray matter volumes at age two years did not differ between children who had MRI-confirmed asymptomatic subdural hemorrhages when they were neonates, compared to children with no history of subdural hemorrhage.

New model of human brain 'conversations' could inform research on brain disease, cognition
A team of Indiana University neuroscientists has built a new model of human brain networks that sheds light on how the brain functions.

Human brain size gene triggers bigger brain in monkeys
Dresden and Japanese researchers show that a human-specific gene causes a larger neocortex in the common marmoset, a non-human primate.

Unique insight into development of the human brain: Model of the early embryonic brain
Stem cell researchers from the University of Copenhagen have designed a model of an early embryonic brain.

An optical brain-to-brain interface supports information exchange for locomotion control
Chinese researchers established an optical BtBI that supports rapid information transmission for precise locomotion control, thus providing a proof-of-principle demonstration of fast BtBI for real-time behavioral control.

Transplanting human nerve cells into a mouse brain reveals how they wire into brain circuits
A team of researchers led by Pierre Vanderhaeghen and Vincent Bonin (VIB-KU Leuven, Université libre de Bruxelles and NERF) showed how human nerve cells can develop at their own pace, and form highly precise connections with the surrounding mouse brain cells.

Brain scans reveal how the human brain compensates when one hemisphere is removed
Researchers studying six adults who had one of their brain hemispheres removed during childhood to reduce epileptic seizures found that the remaining half of the brain formed unusually strong connections between different functional brain networks, which potentially help the body to function as if the brain were intact.

Alcohol byproduct contributes to brain chemistry changes in specific brain regions
Study of mouse models provides clear implications for new targets to treat alcohol use disorder and fetal alcohol syndrome.

Scientists predict the areas of the brain to stimulate transitions between different brain states
Using a computer model of the brain, Gustavo Deco, director of the Center for Brain and Cognition, and Josephine Cruzat, a member of his team, together with a group of international collaborators, have developed an innovative method published in Proceedings of the National Academy of Sciences on Sept.

Read More: Brain News and Brain Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to